相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study
Hamidreza Mahmoudi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns
Soheil Tavakolpour et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2021)
Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study
Zeinab Aryanian et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Rituximab: A Review in Pemphigus Vulgaris
James E. Frampton
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Paradoxical reaction to rituximab in patients with pemphigus: a report of 10 cases
Ali Nili et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2020)
Pemphigus: Current and Future Therapeutic Strategies
Dario Didona et al.
FRONTIERS IN IMMUNOLOGY (2019)
Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients
Yuichi Kurihara et al.
JOURNAL OF DERMATOLOGY (2019)
Pneumocystis jirovecii pneumonia infection in pemphigus patients treated with rituximab: an observational nationwide epidemiological study in Taiwan
Kai-Che Wei et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2018)
Is There a Role for Opportunistic Infection Prophylaxis in Pemphigus? An Expert Survey
Yael A. Leshem et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
Fatal infection of Pneumocystis jiroveci pneumonia in a pemphigus patient treated with rituximab
K. C. Wei et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Rituximab as first-line treatment of pemphigus
Enno Schmidt
LANCET (2017)
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
Pascal Joly et al.
LANCET (2017)
Novel presentation of rituximab-induced herpes zoster: urinary retention and acute kidney failure
J. E. F. Diernaes et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Concurrent Cytomegalovirus and Herpes Simplex Virus Infection in Pemphigus Vulgaris Treated with Rituximab and Prednisolone
Hsien-Yi Chiu et al.
ACTA DERMATO-VENEREOLOGICA (2013)
Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial
Balighi Kamran et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2013)
Efficacy and safety of rituximab treatment in Indian pemphigus patients
A. J. Kanwar et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Adjuvant Rituximab Therapy of Pemphigus
Luisa Lunardon et al.
ARCHIVES OF DERMATOLOGY (2012)
Low-dose rituximab is effective in pemphigus
B. Horvath et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Does rituximab increase the incidence of infectious complications? A narrative review
Theodoros Kelesidis et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
A review of the current use of rituximab in autoimmune diseases
Hakan M. Guercan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Polymyositis and pemphigus vulgaris in a patient: Successful treatment with rituximab
Anne Tournadre et al.
JOINT BONE SPINE (2008)
Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins
I. Shimanovich et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
A single cycle of rituximab for the treatment of severe pemphigus
Pascal Joly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients
M. S. Y. Goh et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis
P. P. Sfikakis et al.
CLINICAL IMMUNOLOGY (2007)
Rituximab in autoimmune bullous diseases:: mixed responses and adverse effects
E. Schmidt et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody)
A Dupuy et al.
ARCHIVES OF DERMATOLOGY (2004)
Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
LH Morrison
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder
TG Salopek et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
分享论文
